EWTX
Edgewise Therapeutics, Inc. · Healthcare
Orbimed Advisors LLC bought $5.0M of Edgewise Therapeutics, Inc.
Director and 10% owner
Bought$4,999,995
$11.00Price
454,545Shares
+3%Stake
What EWTX did for a copier
- $1,000 copied at Fri, Jan 26 open, $16.01
- $1,046
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Mar 11 close.
Orbimed Advisors LLC's record
34 other buys with 3 months of prices since 2016: on average −12.8% against the S&P 500, and 12 of 34 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jan 23. Filed Thu, Jan 25, 4:28 PM ET, after the close. Returns use the Jan 26 open and the Mar 11 close. Not investment advice.